• PHP101 Biosimilars are Not Generics from Payer Perspective

    Nov 1, 2011, 00:00

  • PCN158 The Influence of Health Care Policies and Health Care System Distrust on Willingness to Undergo Genetic Testing

    Nov 1, 2011, 00:00

  • PCV54 First-Year Direct Medical Cost of Newly Diagnosed Stable Angina in Hong Kong

    Nov 1, 2011, 00:00

  • PHP2 Describing Trends and Determinants of Non-Opioid Analgesic (NOA) Prescribing in Chronic Non-Cancer Pain Patients in the United States Outpatient Settings

    Nov 1, 2011, 00:00

  • PIN39 Cost Analysis of Antibiotic Therapy of Acute Peritonitis in Ukraine

    Nov 1, 2011, 00:00

  • PHP109 Tendering of Biosimilars in the UK – Does Launch Price Actually Matter?

    Nov 1, 2011, 00:00

  • PGI11 Cost Analysis of Antihelicobacter Therapy of Gastric and Duodenum Ulcer in Ukraine

    Nov 1, 2011, 00:00

  • PHP51 Patient-Centered Care- Challenges for Brazil, Lessons for United States

    Nov 1, 2011, 00:00

  • PMH47 Validity of the Q10 Questionnaire for Diagnosis of Wearing-off Phenomena in Parkinson's Disease- A Q10 Study

    Nov 1, 2011, 00:00

  • PCN4 Effect of Antiemetic Prophylaxis Against Chemotherapy-Induced Nausea and Vomiting with 5-HT3 Receptor Antagonists in Patients with Lymphoma

    Nov 1, 2011, 00:00

  • PMD28 Cost-Effectiveness Analysis of Three Leprosy Case Detection Methods in Northern Nigeria

    Nov 1, 2011, 00:00

  • PIN43 The Total Cost of HIV Patients Treated with ARV Therapy- Real World Evidence from Three Italian Administrative Databases

    Nov 1, 2011, 00:00

  • PMD57 Data Visualization for Business Intelligen Assessing an Online Tool Used for Benchmarking Hospital Procedure Costs to Reimbursment in Cardiac Catheterization and Electophysiology Procedures

    Nov 1, 2011, 00:00

  • PMH35 A Cost-Effectiveness Analysis of Paliperidone Palmitate Versus Olanzapine Pamoate in the Treatment of Schizophrenia in Norway

    Nov 1, 2011, 00:00

  • PHP60 Drug-related Morbidity – Modeling the Cost-of-Illness in Sweden Using Pharmacists' Opinion

    Nov 1, 2011, 00:00

  • PIH2 Caress- The Canadian Registry of Synagis (2005-2010)

    Nov 1, 2011, 00:00

  • PCV18 Relative Efficacy of Bivalirudin vs. Heparin Alone in STEMI Patients Treated with Primary PCI – an Indirect Treatment Comparison

    Nov 1, 2011, 00:00

  • PCV85 Cost-Effectiveness of Increasing Statin Adherence for Secondary Prevention in Community Pharmacies

    Nov 1, 2011, 00:00

  • PCN52 Economic Impact of Healthcare Resource Utilisation Patterns Among Patients Diagnosed with Advanced Melanoma in the UK, Italy, and Fran Results From a Retrospective, Longitudinal Survey (Melody Study)

    Nov 1, 2011, 00:00

  • PCV7 Cost-Effectiveness of Prasugrel Versus Clopidogrel in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention in the Public Health Care System in Mexico

    Nov 1, 2011, 00:00

  • PSY12 Laparoscopy Versus Open Roux-en-y Gastric Bypass For Morbid Obesity- Cost-Utility Analysis

    Nov 1, 2011, 00:00

  • PMD76 Are Health Technology Assessments of Medical Devices Catching up with Pharmaceuticals?

    Nov 1, 2011, 00:00

  • Instructions for Authors

    Nov 1, 2011, 00:00

  • PHP87 Patient-Centered Health Care Delivery Systems- A Discrete Choice Experiment

    Nov 1, 2011, 00:00

  • PDB32 Cost of Diabetes and its Complications in Poland- Preliminary Results

    Nov 1, 2011, 00:00

  • PSS38 3-D Study - Description of the Care of the Dental Pain

    Nov 1, 2011, 00:00

  • ISPOR 14th Annual European Congress Research Abstracts Author Index

    Nov 1, 2011, 00:00

  • PHP72 Evidence-Based Priority Setting for the National Health Development Plan of Thailand

    Nov 1, 2011, 00:00

  • PMS73 Epidemiology, Therapy Patterns and Functional Status of Patients with Juvenile Idiopatic Arthritis (JIA) in Russia

    Nov 1, 2011, 00:00

  • PDB4 Characterization of the Risk for Urinary Tract Infections in US Patients with Type 2 Diabetes Mellitus

    Nov 1, 2011, 00:00

  • PCV58 the Impact of Comorbid Mental Illness on Costs of Health Care for Inpatients with Heart Failure

    Nov 1, 2011, 00:00

  • PCV13 Comparing the Effectiveness of Rosuvastatin and Atorvastatin in Preventing Cardiovascular Events for Populations Stratified by Baseline Cardiovascular Risk- Estimates Using the Archimedes Model

    Nov 1, 2011, 00:00

  • PHP132 Use of a Disease Specific Quality of Life Tool in a Quality Assurance Scheme for Day Case Hernia Surgery

    Nov 1, 2011, 00:00

  • PRS14 Estimating the Budget Impact of Introducing Indacaterol in the Treatment Of Chronic Obstructive Pulmonary Disease (COPD) from the Public Payer Perspective in SÃo Paulo

    Nov 1, 2011, 00:00

  • PCN95 The Cost-Effectiveness of Aprepitant for the Prevention of Nausea and Vomiting Induced by Moderately Emetogenic Chemotherapy in Breast Cancer Patients Compared to Current Clinical Practice in Scotland

    Nov 1, 2011, 00:00

  • PMH73 Increasing Use of Medication for Treatment of Attention-Deficcit/Hyperactivity Disorder (ADHD) in Germany between 2003 and 2009

    Nov 1, 2011, 00:00

  • PIH18 Rotavirus Gastroenteritis in Vulnerable Children- A UK Case Control Study

    Nov 1, 2011, 00:00

  • PCN142 Methodological Limitations of Patient-Reported Outcome Measures (PROMs) in oncology- A Meta-Review

    Nov 1, 2011, 00:00

  • PRM1 attaching Value to Non-Efficacy Metrics- A Pricing Study

    Nov 1, 2011, 00:00

  • PDB26 Projected Long-Term Clinical and Economic Outcomes of Exenatide Once Weekly Versus Sitagliptin for the Treatment of Type 2 Diabetes in the UK

    Nov 1, 2011, 00:00

  • PIN49 Cost-Effeectiveness of Earlier Initiation of First Line Combination Antiretroviral Therapy in an Urban Outpatient HIV Clinic in Uganda

    Nov 1, 2011, 00:00

  • PIN44 Cost-Effectiveness of Quadrivalent HPV Vaccination in Germany Using A Dynamic Transmission Model

    Nov 1, 2011, 00:00

  • PSY34 Economic Evaluation of Ferinject in the Treatment of Anemia Patients in the Greek Hospital Setting- a Cost Minimization Analysis

    Nov 1, 2011, 00:00

  • PMD45 Optar Study- Transcatheter Aortic Valve Implantation (TAVI) versus Optimal Medical Treatment (OMT) in prohibitive Surgical Risk Patients with Severe Aortic Stenosis (AS) – An Exploratory Cost-Effectiveness Analysis

    Nov 1, 2011, 00:00

  • PRM32 Feasibility and Validity of the TiC-P

    Nov 1, 2011, 00:00

  • PHP112 Inter-Individual Country Variability in Monoclonal Antibodies (MABS) Reimbursement and Coverage Following EMA Approval

    Nov 1, 2011, 00:00

  • PCV106 Predictors of Health Related Quality of Life in a Hypertensive Population

    Nov 1, 2011, 00:00

  • PHP39 Gauging the Role of HTA in Reimbursement Decision-Making Across Five Markets in Latin America

    Nov 1, 2011, 00:00

  • PSY29 Economic Evaluation of Capsaicin Patch 8% in the Treatment of Neuropathic Pain in Austria

    Nov 1, 2011, 00:00

  • PCN34 Cost Analysis of Anemia Treatment with Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in Italy

    Nov 1, 2011, 00:00

  • PDB57 Polish Health Care System for Diabetic Patients- The Analysis of Current Health Care System and the Need of Community Pharmacy Implementation

    Nov 1, 2011, 00:00

  • PCN48 Costs of Tuberous Sclerosis Complex (TSC) Neurological and Developmental Manifestations in Brazil

    Nov 1, 2011, 00:00

  • PMD53 Pulmonary Vein isolation for the Treatment of Paroxysmal AF- Time reduction and productivity Gain with “anatomically-Designed” Cathethers Compared to “Point by Point” Catheters

    Nov 1, 2011, 00:00

  • PCV98 Estimating Willingness to Pay for Hypertension Outpatient Benefit Packages

    Nov 1, 2011, 00:00

  • PMH68 Differential Use of Extended and Instant Release Quetiapine- A Naturalistic Study of Finnish Inpatients with Schizophrenia Spectrum or Bipolar Disorders

    Nov 1, 2011, 00:00

  • PCN26 Long-Term Fiscal Implications of Mepact in the Treatment of High-Grade Non-Metastatic Osteosarcoma- A Budget Impact Model and A Lifetime Tax Perspective

    Nov 1, 2011, 00:00

  • PCV28 Control of Hypertension in Spain- A Systematic Review and Meta-Analysis of 76 Epidemiological Studies on 341,632 Participants

    Nov 1, 2011, 00:00

  • PMH4 Economic Assessment Of Major Depressive Disorder Treatment Under Different Therapeutic Classes At Issste

    Nov 1, 2011, 00:00

  • PDB21 Natural History of Beta Cell Rate of Decline and Its Effect on Development of Secondary Complications in Type 1 Diabetes

    Nov 1, 2011, 00:00

  • CN4 Evaluacion De Costos Del Tratamiento De Primera Linea Para Cancer Colorrectal Metastasico (Mcrc) Con Esquemas Basados En- Folfiri, Folfox O Xelox Mas Bevacizumab, En Cinco Instituciones Mexicanas

    Nov 1, 2011, 00:00

  • PHP156 Novel Drug Reimbursement Models- Lessons and Implications from Cancer Drug Access Schemes

    Nov 1, 2011, 00:00

  • PMH39 Cost Effectiveness of A Collaboratieve Care Stepped intervention for Anxiety Disorders in the Primairy Care Setting

    Nov 1, 2011, 00:00

  • PMD59 Complicated Parkinson'S Disease- Discrete Choice Analysis to Assess Patients' Preferences. A Pilot Study

    Nov 1, 2011, 00:00

  • PDB5 Micro- and Macrovascular Outcomes in Primary Care Patients with Type 2 Diabetes Treated with Insulin Glulisine or Human Regular Insulin- A Retrospective German Database Analysis

    Nov 1, 2011, 00:00

  • PIH35 The Measurement and Valuation of Health Status Using EQ-5D in Brazil- A Systematic review

    Nov 1, 2011, 00:00

  • PDB75 Analysis of the Medicines Pricing Procedure in the Republic of Macedonia

    Nov 1, 2011, 00:00

  • PIN73 Modeling the Long Term Clinical Outcomes and Health Care Cost Impact of Initiating Treatment with Atazanavir/R Compared with Darunavir/R, Lopinavir/R and Efavirenz for HIV-1 Infected Treatment-NaÏve Patients- Country Results for Italy ...

    Nov 1, 2011, 00:00

  • PCN131 Systematic Evaluation of Specific Quality of Life Instruments for Prostate Cancer

    Nov 1, 2011, 00:00

  • PIH55 Necessity of Admissions and Hospitalizations in Selected Teaching University Affiliated and Private Hospitals of Shiraz, Iran in 2007

    Nov 1, 2011, 00:00

  • PMD34 Cost Effectivness of Ambulatory Cardiac Monitor versus Holter

    Nov 1, 2011, 00:00

  • PCV125 The Increasing Burden of Atrial Fibrillation on Health Care in Scotland

    Nov 1, 2011, 00:00

  • PMS42 Cost-Effectiveness of Increasing Bisphosphonates Adherence for Osteoporosis in Community Pharmacies

    Nov 1, 2011, 00:00

  • DA3 The Power of Assumptions

    Nov 1, 2011, 00:00

  • PHP96 Mitigating Emergency Department Over-Crowding Utilizing Focused Operations Management Tools

    Nov 1, 2011, 00:00

  • HT1 Effectiveness, Efficiency and Budget Impact Affect The Belgian Drug Reimbursement Decision (DRD)

    Nov 1, 2011, 00:00

  • PCV121 The Economic and Humanistic Burden of Acute Coronary Syndrome (ACS)- A Systematic Review

    Nov 1, 2011, 00:00

  • Editorial Board

    Nov 1, 2011, 00:00

  • PMH69 Deprivation and Use of Atipycal Antipsychotics in Schizophrenia

    Nov 1, 2011, 00:00

  • PMH57 Association of Antidepressant-Related Weight Gain with Degree of Enjoyment and Satisfaction Regarding General Daily Activities, Medication and Overall Quality of Life

    Nov 1, 2011, 00:00

  • PSY48 Health-related Quality of Life in Russian Patients With Inhibitor Hemophilia

    Nov 1, 2011, 00:00

  • PND16 Health Economics of Sclerosis Multiplex in Slovakia

    Nov 1, 2011, 00:00

  • PCV47 Analysis of Transient Ischemic Attack-Related Clinical Outcomes, Health Care Utilization and Cost Burden of Patients with Non-Valvular Atrial Fibrillation

    Nov 1, 2011, 00:00

  • PHP135 Evaluation of Cost Containment Interventions Introduced on the Community Drug Schemes in Ireland Using A National Prescrption Claims Database

    Nov 1, 2011, 00:00

  • PMH50 Differences Between Opioid Dependent Patients in Italy and Germany Receiving Substitution Therapy

    Nov 1, 2011, 00:00

  • PHP153 Some Shortages and Alternatives to the Patent System for Pharmaceuticals

    Nov 1, 2011, 00:00

  • PMH2 The COST-Effectiveness Of Paliperidone Palmitate Compared To Olanzapine Pamoate In The Treatment Of Schizophrenia In Sweden

    Nov 1, 2011, 00:00

  • PND58 A Real World Evaluation of the Time Associated with Administration of A Single Episode of Treatment in Patients with Hereditary Angioedema (HAE) in the Home and Hospital Environment

    Nov 1, 2011, 00:00

  • PMS48 Cost-Utility of Denosumab for the Treatment of Postmenopausal Osteoporosis in Spain

    Nov 1, 2011, 00:00

  • PMD7 Effectiveness and Self-Monitoring of Blood Glucose (SMBG) Frequencies in Poorly-Controlled Patients with Non-insulin-Treated Diabetes (NITDM) Who Were Not Active Testers Prior to the Step Study

    Nov 1, 2011, 00:00

  • PMS34 Cost-Effectiveness Analysis of Bio- Hyaluronic Acid (HA) in Patients with Knee Osteoarthritis in Mexico

    Nov 1, 2011, 00:00

  • PSS34 Qualitative Grounding for A New Patient Assessment Measure in Ophthalmology- The Functional Assessment of Visual Tasks (Vistas)

    Nov 1, 2011, 00:00

  • PCN201 Cost-Effectiveness Literature on Cancer Therapies, Trends and the Influence of Industry Involvement on Outcomes

    Nov 1, 2011, 00:00

  • PUK8 Chronic Kidney Disease Burdens Patients, Health Care Systems, and Employers

    Nov 1, 2011, 00:00

  • PMH62 An Examination of the Association Between Antidepressant-Related Weight Gain and Various Aspects of Worker Productivity

    Nov 1, 2011, 00:00

  • PCV112 A Comparison of European Health Care Systems on Stroke Prevention in Atrial Fibrillation – Interim Results of a Patient Satisfaction Survey

    Nov 1, 2011, 00:00

  • PCN180 Threshold Values for Cost-Effectiveness in AHTAPol and NICE for Cancer Drug Technologies

    Nov 1, 2011, 00:00

  • PIH65 What Are We Missing in Meningococcal Disease Modelling to Better Understand the Health and Economic Impact of New Vaccines?

    Nov 1, 2011, 00:00

  • PCV134 Concomitant Medciation Use in US Adults on Statin Therapy- Findings from a Multi-Employer Claims Database

    Nov 1, 2011, 00:00

  • PRS1 Budget Impact analysis of Fluticasone Furoate (FFNS) in Treatment of Allergic Rhinitis Patients in Mexico

    Nov 1, 2011, 00:00

  • PCN98 Estimating the Potential Cost-Effectiveness of Human Papillomavirus (HPV) Vaccination in Germany Using A Dynamic Transmission Model

    Nov 1, 2011, 00:00

  • PRM50 Sample Size and Ethical Considerations in Randomized Cluster Sampling Versus Individual Patient Recruitment Formulas in Prospective Observational Studies

    Nov 1, 2011, 00:00

  • PGI24 Burden of Gastroesophageal Reflux Disease Among Patients With Persistent Symptoms Despite Proton Pump Inhibitor Therapy- An Observational Study in France

    Nov 1, 2011, 00:00

  • PMH52 Relationship Between Psychopathology and Self-Rated EQ-5D Health States Among Patients With Schizophrenia

    Nov 1, 2011, 00:00

  • PMD38 Cost-Effectiveness of the Cardiovascular Marker ST2 in Providing Risk Stratification After Acute Heart Failure

    Nov 1, 2011, 00:00

  • PIH31 Anti-Viral Treatment of Chronic Hepatitis C in a Paediatric Population- A Cost-Effectiveness Analysis

    Nov 1, 2011, 00:00

  • PCN182 What Kind of Changes Did the Publication of Two Large-Scale RCTs Lead to in Prostate Cancer Screening Guidelines?

    Nov 1, 2011, 00:00

  • PMH37 Cost-Minimisation Analysis of Asenapine Monotherapy Versus Other Antipsychotics in Bipolar I Disorder in Two Nordic Countries

    Nov 1, 2011, 00:00

  • PIN51 A Cost-Effectiveness Analysis of Linezolid Versus Vancomycin for Ventilator-Associated Pneumonia Patients in Panama

    Nov 1, 2011, 00:00

  • MA1 Mapping the EQ-5D Index from I-QOL in Idiopathic and Neurogenic OAB Patients- Results from A Cross-Sectional Study in the United States and Four European Countries

    Nov 1, 2011, 00:00

  • PGI1 incidence and Cost of Treatment-Emergent Comorbid Events in an Insured Population Receiving Treatment for Chronic Hepatitis C (CHC) Virus Infection

    Nov 1, 2011, 00:00

  • PMD23 Characterization of Focal Liver Lesions by Contrast-Enhanced Ultrasound in the Netherlands- An Economic Evaluation

    Nov 1, 2011, 00:00

  • PHP74 Considerable Potential Savings from Change in Distribution Channel for Serious Diseases Products in Gree The Case of OGA Social Security Fund (SSF)

    Nov 1, 2011, 00:00

  • PDB2 Calidad De Prescripcion De Hipoglucemiantes orales En Una Unidad Medica Familiar- Centro, Tabasco, MÉxico, 2009

    Nov 1, 2011, 00:00

  • PHP24 How Does the Committee to Evaluate Drugs (CED) Make Decisions about Ambulatory Pharmaceutical Funding in Ontario?

    Nov 1, 2011, 00:00

  • PRS2 Costos De atencion Medica atribuibles Al Consumo De Tabaco En México

    Nov 1, 2011, 00:00

  • PCN55 The Economic Burden of Adjuvant Chemotherapy in Germany

    Nov 1, 2011, 00:00

  • PCN94 Comparative Analysis of Cost-Effectiveness Bevacizumab + Paclitaxel Versus Using Only Versus Paclitaxel as First Line Treatment of Patients with Metastatic Breast Cancer in the IMSS (Mexican Institute of Social Security)

    Nov 1, 2011, 00:00

  • PSS36 Demonstrating Conceptual Equivalen Translation of the Cu-Q2Ol From Italian into English

    Nov 1, 2011, 00:00

  • PCV15 Guidelines Adherence and Hypertension Control in Patients Suffering from Cardiovascular Disease

    Nov 1, 2011, 00:00

  • PCN165 A First Estimate of the Incremental Impact of Males HPV Vaccination on HPV-Related Diseases in Europe

    Nov 1, 2011, 00:00

  • PHP43 Exploring Social Determinants of the Health of International Immigrants in Chile- The Global Health Status Index

    Nov 1, 2011, 00:00

  • PRM12 An Application of a Proposed Framework for Formulary Listing in Low-income Countries- Case of Côte d'Ivoire

    Nov 1, 2011, 00:00

  • PHP124 Personalized Decision Making in Cancer Medicine? Systematic Overview of HTA Procedures and Specific Approaches in Ten Countries Across Four Continents

    Nov 1, 2011, 00:00

  • PMH77 Prescription Pattern Evaluation for Bipolar Disorder in a Treatment Facility in India

    Nov 1, 2011, 00:00

  • PSY8 Neuropathic Pain- a Budget Impact Analysis to Estimate Costs Due to the Introduction of Qutenza® on the Spanish Market

    Nov 1, 2011, 00:00

  • AD3 Assessing The Compliance And Persistence of Allergen Immunotherapy In Allergic Rhinitis Using A Retrospective Pharmacy Database From The Netherlands

    Nov 1, 2011, 00:00

  • PDB49 Resource Use in Patients with Type 2 Diabetes (T2D) Who Initiated Exenatide BID (EXBID) or Starter Insulin (INS) Therapy- 6-Month Data from Choice

    Nov 1, 2011, 00:00

  • PHP64 Reorganisation of Hospital Emergency Services- A Business Case for Quality Improvement

    Nov 1, 2011, 00:00

  • PDB20 A1C Variability and the Risk of Developing New Diabetes for the Healthy Adults in Japan

    Nov 1, 2011, 00:00

  • PCV59 Annual Medical Expenditure and Mortality Related to Acute Coronary Syndrome (ACS) in the United Kingdom – A Systematic Review

    Nov 1, 2011, 00:00

  • PIN24 Potential Costs Associated with New Direct Acting Antiviral (DAAs) Therapy for Untreated Chronic Hepatitis C Genotype 1 Infection in the Veterans Health Administration

    Nov 1, 2011, 00:00

  • PMD84 Assessing Cost Effectiveness and Value of Further Research When Data are Sparse- Negative Pressure Wound Therapy for Severe Pressure Ulcers

    Nov 1, 2011, 00:00

  • PSS10 Economic Outcomes of Glaucoma Treatment With Prostaglandin Eye Drops Preserved With Polyquad® Instead of Benzalkonium Chloride in Germany

    Nov 1, 2011, 00:00

  • PCN1 Selecting a Mix of Prevention Strategies Against Cervical Cancer for Maximum Efficiency with an Optimisation Program

    Nov 1, 2011, 00:00

  • PSY31 Cost-Effectiveness of Tapentadol Prolonged-Release (Pr) Compared to Oxycodone Controlled Release (Cr) in Patients with Chronic Severe Non-Cancer Pain in Ireland

    Nov 1, 2011, 00:00

  • PIN59 A Cost-Effectiveness Analysis of Voriconazol, Anfotericine B and Caspofungin for Invasive Aspergilosis Patients in Panama

    Nov 1, 2011, 00:00

  • PND61 Impact of Patient Cost-Sharing Arrangements for Disease Modifying Therapies on Treatment Compliance among Patients with Multiple Sclerosis in the United States

    Nov 1, 2011, 00:00

  • PCN11 Bevacizumab in Combination with Chemotherapy for the First-Line Treatment of Metastatic Colorectal Cancer

    Nov 1, 2011, 00:00

  • PMS59 Inadequate Pain Relief in Knee Osteoarthritis and Patient Reported outcomes- A Survey of Osteoarthritis Real World Therapies (SORT) in the United Kingdom

    Nov 1, 2011, 00:00

  • PIH21 the Potential Public Health Benefit of Pneumococcal Conjugate Vaccines in the Kingdom of Saudi Arabia

    Nov 1, 2011, 00:00

  • PCN35 Capecitabine for the Treatment of Colorectal Cancer in Private Health System in Brazil- A Budgetary Impact Analysis Based on Real World Data

    Nov 1, 2011, 00:00

  • PRS16 Cost Analysis of Haemostatic Treatment with a Fibrin-Based Sponge Versus Fibrin Sealant in Lung Surgery and Liver Resection in a Spanish Setting

    Nov 1, 2011, 00:00

  • PHP138 Intangible Capital and Return on Assets in the Pharmaceutical Industry

    Nov 1, 2011, 00:00

  • PSY33 Clinical and Economic Analysis of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura in Context of Russian Health Care System

    Nov 1, 2011, 00:00

  • PIH4 A Comparative Study of Respiratory Syncytial Virus (RSV) Prophylaxis in Premature Infants

    Nov 1, 2011, 00:00

  • PMS74 Use of Disease-Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis in Quebec, Canada

    Nov 1, 2011, 00:00

  • PRS6 Cost-Effectiveness of Fluticasone Furoate Compared with Mometasona Furoate for the Primary Treatment of Allergic Rhinitis Patients

    Nov 1, 2011, 00:00

  • PMS55 Persistence to Osteoporosis Treatment and its association to the Risk of Fracture Among Women in Taiwan

    Nov 1, 2011, 00:00

  • PSS39 Assessment of the Health Status Using the 12-Item Medical Outcomes Study Short Form (SF-12) Questionnaire (2578 Dermatological Out-Patients)

    Nov 1, 2011, 00:00

  • PND54 Quality of Life Impairment, Disability, and Economic Burden Associated with Chronic Daily Headache Focussing on Chronic Migraine With or Without Medication Overuse- A Systematic Review

    Nov 1, 2011, 00:00

  • PND31 A Modelled Economic Evaluation of Firazyr® (Icatibant) for Symptomatic Treatment of Acute Attacks of Hereditary Angioedema (HAE) in Adults with C1-Esterase-Inhibitor (C1-INH) Deficiency

    Nov 1, 2011, 00:00

  • PCN187 Treatment Patterns in Patients with Metastatic Melanoma

    Nov 1, 2011, 00:00

  • HG2 Characterizing The Individual Course of Health-Related Quality of Life After Subarachnoid Hemorrhage

    Nov 1, 2011, 00:00

  • PCN160 Prostate Cancer Screening Practices in the Republic of Ireland- The Determinants of Uptake

    Nov 1, 2011, 00:00

  • PCV72 Long-Term Cost Effectiveness Analysis of Ticagrelor in Patients with Acute Coronary Syndrome from a Polish Health Care Perspective

    Nov 1, 2011, 00:00

  • PCN5 Reduced Risk of Chemotherapy-Induced Nausea and Vomiting in Patients with Cancer Treated with Highly Emetogenic Chemotherapy and Antiemetic Prophylaxis With Palonosetron

    Nov 1, 2011, 00:00

  • PMD80 Patient Demographics and Surgical Expenditure in Hernia repair Surgical Cohorts Using A retrospective Nationwide Patient Database

    Nov 1, 2011, 00:00

  • PUK1 Comparison Of Direct Medical Cost Of Dialysis In A Mexican Cohort Either On Peritoneal Or Hemodialysis

    Nov 1, 2011, 00:00

  • CN3 Cost Effectiveness of Liposomal Doxorubicin Versus Paclitaxel for the Treatment of Aids-Ks

    Nov 1, 2011, 00:00

  • PSU2 Comparison of Seizure and Hydrocephalus and Other Clinical Conditions Before and After Subependymal Giant Cell Astrocytoma Surgery in Patients with Tuberous Sclerosis Complex

    Nov 1, 2011, 00:00

  • PSY39 Predictors of Health Utilities Among Patients with Rheumatoid Arthritis in Europe

    Nov 1, 2011, 00:00

  • PSY6 Estudio De COSTO-Efectividad De Buprenorfina TRANSDÉrmica Versus Oxicodona Oral Y Fentanilo TRANSDÉrmico En El Manejo Del Dolor CRÓnico No OncolÓgico En El Hospital San JosÉ De Bogotá D.C. Enero-Diciembre 2010

    Nov 1, 2011, 00:00

  • PCV3 Thromboprophylaxis Use and Venous Thromboembolism, Major and Minor Bleeding Event Analysis in Hospitalized Medically Ill Patients

    Nov 1, 2011, 00:00

  • PRS67 Consumption Patterns and in Vitro Resistance of S. Pneumoniae to Fluoroquinolones

    Nov 1, 2011, 00:00

  • PMD1 Nd-Yag Laser Incidence Rate Comparison of Three Monofocal Intraocular Lenses (IOL) 36 Months after Cataract Surgery in France

    Nov 1, 2011, 00:00

  • PND44 Validation of the Fabry Outcome Survey (FOS) Paediatric Health and Pain Questionnaire

    Nov 1, 2011, 00:00

  • PSY24 Pregabalin is Cost-Saving in Comparison with Gabapentin Treated Patients when Added to Existing Therapy in the Management of Painful Radiculopathies

    Nov 1, 2011, 00:00

  • PHP66 Impact of Type of Drug Insurance on the Use of Health Care Services Among Users of Antidepressants

    Nov 1, 2011, 00:00

  • PHP15 Implications of Latin American Pharmaceutical Pricing Reform for the UK NHS

    Nov 1, 2011, 00:00

  • PRM52 Socioeconomic Patterns Among International Immigrants in Chile- The Use of Clusters

    Nov 1, 2011, 00:00

  • PIH13 Generalising the Output of Rotavirus Vaccination Impact Studies- What Can We Learn?

    Nov 1, 2011, 00:00

  • PHP29 Impact of Different Pharmaceutical Distribution Systems on the Access to Pharmaceutical Products in Six European Countries

    Nov 1, 2011, 00:00

  • PCV60 Cost-Effectiveness of Dabigatran for the Prevention of Stroke in Patients with Non-Valvular Atrial Fibrillation in Australia

    Nov 1, 2011, 00:00

  • PHP29 Predictors of Appropriate Use of Insecticide Treated Nets in an Urban Community- The Case of Asokwa Sub-Metropolitan Area, Kumasi, Ashanti, Ghana

    Nov 1, 2011, 00:00

  • PCN7 Impacto Presupuestario Del Tratamiento En Primera LÍnea Para CÁncer Colorrectal MetastÁsico Basado En XELOX + anti-VEGF o XELOX + anti-EGFR

    Nov 1, 2011, 00:00

  • PHP123 To What Extent Does Advice from the Scottish Medicines Consortium (SMC) Agree with That Published by NICE?

    Nov 1, 2011, 00:00

  • PRM48 A Model for Patients Accrual in Multi-Site Observational Studies- A Survival Analysis Approach

    Nov 1, 2011, 00:00

  • CN2 Measuring Public Preferences For Colorectal Cancer Screening Using New Genome-Based Nanotechnologies

    Nov 1, 2011, 00:00

  • PIN61 Cost of Virologic Response with Two Active Drugs in the Optimized Background Therapy with Etravirine, Raltegravir, and Maraviroc in the Brazilian National AIDS Program

    Nov 1, 2011, 00:00

  • PHP25 Designing Feasible Models for an Optimal Pharmaceutical Consultation Program Using A Systematic Review

    Nov 1, 2011, 00:00

  • PHP134 Comparison of the Knowledge in Standard Treatment Guidelines among Medical Practitioners and Medical Students

    Nov 1, 2011, 00:00

  • PHP149 Perception of Pharmaceutical Companies on the Drug Price-Volume Negotiation in South Korea

    Nov 1, 2011, 00:00

  • PMD6 Efficacy and Safety of Artificial Disc Arthroplasty Compared to Surgical Fusion for Single Level Cervical and Lumbar Degenerative Disc Disease- A Bayesian Meta-analysis

    Nov 1, 2011, 00:00

  • PHP25 Validity and Reliability of Instruments Used for Measuring Patient Satisfaction with Pharmaceutical Care Services

    Nov 1, 2011, 00:00

  • PIN86 Interim Results on Adherence to Treatment of Chronic C Hepatitis Monoinfected and HCV/HIV Co-infected Patients Assessed by the Adhepta Questionnaire

    Nov 1, 2011, 00:00

  • PMD82 Drug Eluting Balloon for the Treatment of peripheral Artery Disease- A Cost-Effectiveness analysis in Italy

    Nov 1, 2011, 00:00

  • PIN105 Financial Support for HIV/AIDS Prevention, Care and Treatment in Thailand

    Nov 1, 2011, 00:00

  • PMS30 Cost-Effectiveness of Tocilizumab Compared to Standard Therapeutic Sequences for the Treatment of Moderate/Severe Rheumatoid Arthritis (RA) Patients in Portugal

    Nov 1, 2011, 00:00

  • PRS8 Cost-Effectiveness of an Ambulatory program of Pulmonary rehabilitation following Acute Exacerbations of Copd in Colombia

    Nov 1, 2011, 00:00

  • PHP148 Global Pharmaceutical Risk-Sharing Agreement Trends in 2010 and 2011

    Nov 1, 2011, 00:00

  • PIN108 Sustained Virological Response as Patient-Relevant Endpoint in Hepatitis C?

    Nov 1, 2011, 00:00

  • PIN97 How Does Health-Related Quality of Life Relate to Symptoms Experience in HIV Patients Treated with Highly-Active Antiretroviral Therapy?

    Nov 1, 2011, 00:00

  • PSS12 C-Reality (Canadian Burden of Diabetic Macular Edema Observational Study)- Three-Month Findings

    Nov 1, 2011, 00:00

  • PHP42 Drug Consumption in Bosnia and Herzegovina - Comparison to Neighboring Country

    Nov 1, 2011, 00:00

  • PHP75 The Cost Per Day of Intensive Care Units (ICU) in Fran The CRRÉA Study

    Nov 1, 2011, 00:00

  • PCN111 Cost-Effectiveness of Human Papillomavirus Vaccination for Prevention of Cervical Cancer in Roraima, A Brazilian Amazonic Region State

    Nov 1, 2011, 00:00

  • PIH54 Analysis of the Formulary Ensure Children's Hospitals in Ukraine- First Results

    Nov 1, 2011, 00:00

  • PCN81 A Cost-Effectiveness Analysis of Adjuvant Trastuzumab Regimens in Early HER2/NEU-Positive Breast Cancer in Colombia

    Nov 1, 2011, 00:00

  • PSY19 Economic Costs of Chemotherapy-Induced Febrile Neutropenia Among Patients with Non-Hodgkin'S Lymphoma in European Clinical Practice

    Nov 1, 2011, 00:00

  • Table of Contents

    Nov 1, 2011, 00:00

  • PHP24 ComparaÇÃo Da qualidade De Vida Entre Pessoas Com DoenÇas Crónicas E Pessoas Da Comunidade Sem DoenÇa

    Nov 1, 2011, 00:00

  • PCN198 Review of Economic Assessments of Emerging Genomic Technologies in Oncology

    Nov 1, 2011, 00:00

  • PCN167 National Formulary Review of the Drugs Used in Pancreatic Neuroendocrine Tumors in Korea

    Nov 1, 2011, 00:00

  • PR3 Primary Health Care Evaluation in Chile- Patients’ Perspective

    Nov 1, 2011, 00:00

  • PDB82 Development of a Health Economic Model to Compare the Prevention, Treatment and Management Strategies of Type 2 Diabetes

    Nov 1, 2011, 00:00

  • PMH20 Health Care Cost Comparisons between Alcohol or Opioid- Dependent Patients Who Were Treated with Medication and Those Who Were Not

    Nov 1, 2011, 00:00

  • PSS37 the Clinical and Economic Burden of Acute Otitis Media- A Large Prospective Observational Cohort Study in Europe

    Nov 1, 2011, 00:00

  • PSY47 Evaluating the Cross-over Effect on Health-related Quality of Life in a Randomized Cross-over Study of Hemophilia-A Patients

    Nov 1, 2011, 00:00

  • PR1 Key Market Access Drivers for A Successful Health Technology Appraisal outcome – The Case of Rheumatoid Arthritis

    Nov 1, 2011, 00:00

  • PCV96 Cost-Utility Analysis of the Long-Term Cardiovascular Prevention Program in Russian Federation as an Argument for the Widespread Introduction of Preventive Technologies Into Clinical Practice

    Nov 1, 2011, 00:00

  • PND4 A Meta-analysis of the Duration of Clinical Effect of onabotulinumtoxina in Cervical Dystonia

    Nov 1, 2011, 00:00

  • PCN135 Influence of Economic Implications Related to the Prescription of Oral and Intravenous Chemotherapy on Physicians' Preferences- A Discrete Choice Experiment

    Nov 1, 2011, 00:00

  • PCV53 Cost Study of Caregiving for Patients with Chronic Symptomatic Heart Failure in Spain, Insights from the Inoescaro Study

    Nov 1, 2011, 00:00

  • PHP107 Clinical Trial Activity in Gree Opportunities Missed, Soon to be Forgone?

    Nov 1, 2011, 00:00

  • PDB71 Cross-Sectional Analysis of Ambulatory Care Expenditure Among Patients with Type 2 Diabetes Mellitus (T2DM) According to Treatment Stage and Renal Function in France Using EGB Database (Echantillon Generaliste De Beneficiaires)

    Nov 1, 2011, 00:00

  • PDB35 Estimating the Real Life Daily Usage and Daily Cost of GLP-1 Receptor Agonists in the UK Setting

    Nov 1, 2011, 00:00

  • PHP5 Modelo Teorico De Un Consumidor- Seleccion Entre Un Biosimilar Y Un Biotecnologico De Patente Basado En Preferencias

    Nov 1, 2011, 00:00

  • PHP44 Inappropriate Prescriptions Based on Beers Criteria in Elderly Patients Treated at Home

    Nov 1, 2011, 00:00

  • PRS11 Budget Impact Analysis of Immunotherapy in Patients with Birch Allergic Rhinitis

    Nov 1, 2011, 00:00

  • PMS58 Pilot Validation of the Brief Fatigue Inventory ‘Fatigue at its Worst’ Item in Patients with Rheumatoid Arthritis

    Nov 1, 2011, 00:00

  • PCN60 Economic Evaluation of Vaccination Against Cervical Cancer in the Moscow Region

    Nov 1, 2011, 00:00

  • PCN4 Costo-Efectividad De Octreotide Comparado Con Terapia De Soporte Usual Para El Tratamiento De Tumores Neuroendocrinos En Colombia

    Nov 1, 2011, 00:00

  • PMD18 Mast (Minimal Access Spinal Technologies) versus Open Surgery- Activity-Based Cost analysis of Spinal Fusion procedure from Hospital Perspective

    Nov 1, 2011, 00:00

  • PCN109 Cost Effectiveness of First Line Tyrosine Kinase Inhibitor Treatment in Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients- A Markov Model

    Nov 1, 2011, 00:00

  • PCN97 Economic Evaluation of Prophylactic Pegfilgrastim and Filgrastim in Patients with Myeloablative Chemotherapy to Avoid Neutropenia in the IMSS (Mexican Institute of Social Security)

    Nov 1, 2011, 00:00

  • PND53 The Patient-Reported Burden of Impaired Walking in Multiple Sclerosis

    Nov 1, 2011, 00:00

  • PHP26 Health Outcomes and Economics Research for Regenerative Medicine and Cellular Therapies- Lessons From A Multi-Market Health Technology Assessment and Reimbursement review

    Nov 1, 2011, 00:00

  • PDB5 Use of a Discrete Event Simulation Model to Estimate Clinical and Economic Outcomes of Various Self-Monitoring of Blood Glucose Regimes Plus Conventional Pharmacologic Treatment on Type-2 Diabetic Patients in Mexico

    Nov 1, 2011, 00:00

  • PIH27 Potential Health and Economic Impact of Adding Rotarixtm to Routine Infant Vaccination Programs in Canada

    Nov 1, 2011, 00:00

  • PHP145 the Burden of Evidence in the Pharmaceutical Appraisal process

    Nov 1, 2011, 00:00

  • PCN137 Health State Utilities in Breast Cancer

    Nov 1, 2011, 00:00

  • CV1 A Cost-Utility Analysis of Prophylactic Therapy for Venous Thromboembolism with Dabigatran Etexilate or Enoxaparin

    Nov 1, 2011, 00:00

  • PSS40 The Effect of Acute Otitis Media in Children on Parents' Quality of Life- Development and Validation of A Questionnaire Implemented in A Prospective Observational Cohort Study in Europe

    Nov 1, 2011, 00:00

  • PHP104 Identifying Factors Influencing Drug Reimbursement in Scotland

    Nov 1, 2011, 00:00

  • PCV101 Population Based Study - Impact of Adherence to Antihypertensive Agents on Cardiovascular Issues

    Nov 1, 2011, 00:00

  • PCV44 Cost-Utility Associated with Different Monitoring Strategies Among Patients Receiving Long-Term Oral Anticoagulation Therapy in Austria

    Nov 1, 2011, 00:00

  • PMS68 Measuring the Health-Related Quality of Life in Patients with Rheumatoid Arthritis Treated with Adalimumab in Gree Comparing the Results of One Generic (EQ-5D) and One Disease-Specific (HAQ) Instrument

    Nov 1, 2011, 00:00

  • PSY54 A Cost Estimation of the New Guideline to Treat Bleeding Episodes in Patients with Haemophilia and Inhibitors in Iran

    Nov 1, 2011, 00:00

  • PCV118 Observational Study on the Treatment, Cost and Quality of Life of Subjects with Hereditary Angioedema

    Nov 1, 2011, 00:00

  • PHP90 The Reform of the Community Pharmacy in Italy Between New Role and Managerialism

    Nov 1, 2011, 00:00

  • PIH61 A qualitative Evaluation of the Integrated Management of Childhood Illness (IMCI) in Northeastern Brazil and Peru- The Managers' Perspective

    Nov 1, 2011, 00:00

  • PHP53 Assessment of the Attitudes of the General Public Towards Supplementary Criteria to Be Used in PR Decision Making Process in Poland

    Nov 1, 2011, 00:00

  • PIH66 Trait or State- An Exploration of Self-Esteem, Happiness and Quality of Life by Time Series

    Nov 1, 2011, 00:00

  • PHP49 Developing Risk Sharing Arrangements – Potential for Brazil and Implications

    Nov 1, 2011, 00:00

  • PHP28 Decentralisation of Health Services Planning and Management- The Varying Perspectives of Health Workers and Community Members at Nanumba North District, Ghana

    Nov 1, 2011, 00:00

  • PMS32 Economic Analysis of Etanercept in Rheumatoid Arthritis from a Public perspective in Venezuela

    Nov 1, 2011, 00:00

  • Funding Linked to Ongoing Research- Impact of the Bosentan Patient Registry on Pricing in Australia

    Sep 1, 2011, 00:00

  • Economic Evaluation of Everolimus versus Sorafenib for the Treatment of Metastatic Renal Cell Carcinoma after Failure of First-Line Sunitinib

    Sep 1, 2011, 00:00

  • A New Validation of the Spanish Work Productivity and Activity Impairment Questionnaire—Crohn's Disease Version

    Sep 1, 2011, 00:00

  • Development and Validation of the SEC-QOL Questionnaire in Women Using Contraceptive Methods

    Sep 1, 2011, 00:00

  • Modelling Correlated Clinical Outcomes in Health Technology Appraisal

    Sep 1, 2011, 00:00

  • Cost-Effectiveness of a Recommendation of Universal Mass Vaccination for Seasonal Influenza in the United States

    Sep 1, 2011, 00:00

  • Consistency between Direct and Indirect Trial Evidence- Is Direct Evidence Always More Reliable?

    Sep 1, 2011, 00:00

  • Time Trade-Off Derived EQ-5D Weights for Australia

    Sep 1, 2011, 00:00

  • Differential Item Functioning in Quality of Life Measure between Children with and without Special Health-Care Needs

    Sep 1, 2011, 00:00

  • Table of Contents

    Sep 1, 2011, 00:00

  • Erratum

    Sep 1, 2011, 00:00

  • Costs of Care for Dementia Patients in Community Setting- An Analysis for Mild and Moderate Disease Stage

    Sep 1, 2011, 00:00

  • Mapping FACT-Melanoma Quality-of-Life Scores to EQ-5D Health Utility Weights

    Sep 1, 2011, 00:00

  • Instructions for Authors

    Sep 1, 2011, 00:00

  • A Trial-Based Assessment of the Cost-Utility of Bevacizumab and Chemotherapy versus Chemotherapy Alone for Advanced Non-Small Cell Lung Cancer

    Sep 1, 2011, 00:00

  • Cost-Effectiveness of Lanthanum Carbonate in the Treatment of Hyperphosphatemia in Chronic Kidney Disease Before and During Dialysis

    Sep 1, 2011, 00:00

  • Copyright/Subscription

    Sep 1, 2011, 00:00

  • Patient Access to New Cancer Drugs in the United States and Australia

    Sep 1, 2011, 00:00

  • Editorial Board

    Sep 1, 2011, 00:00

  • Comparison of the Underlying Constructs of the EQ-5D and Oxford Hip Score- Implications for Mapping

    Sep 1, 2011, 00:00

  • Cost-Effectiveness of Implantable Defibrillators after Myocardial Infarction Based on 8-Year Follow-Up Data (MADIT II)

    Sep 1, 2011, 00:00

  • How Valid and Responsive Are Generic Health Status Measures, such as EQ-5D and SF-36, in Schizophrenia? A Systematic Review

    Sep 1, 2011, 00:00

  • Esophageal Doppler Monitoring during Colorectal Resection Offers Cost-Effective Improvement of Hemodynamic Control

    Sep 1, 2011, 00:00

  • Patient Preference for Latent Tuberculosis Infection Preventive Treatment- A Discrete Choice Experiment

    Sep 1, 2011, 00:00

  • The Impact of a Revised EQ-5D Population Scoring on Preference-Based Utility Scores in an Inflammatory Arthritis Cohort

    Sep 1, 2011, 00:00

  • Impact of Measures to Enhance the Value of Observational Surveys in Rare Diseases- The Fabry Outcome Survey (FOS)

    Sep 1, 2011, 00:00

  • Measurement Equivalence of Interactive Voice Response and Paper Versions of the EQ-5D in a Cancer Patient Sample

    Sep 1, 2011, 00:00

  • Hospitalization Costs for Heart Failure in People with Type 2 Diabetes- Cost-Effectiveness of its Prevention Measured by a Simulated Preventive Treatment

    Jul 1, 2011, 00:00

  • Table of Contents

    Jul 1, 2011, 00:00

  • Bridging Trial and Decision- A Checklist to Frame Health Technology Assessments for Resource Allocation Decisions

    Jul 1, 2011, 00:00

  • Calibrating Longitudinal Models to Cross-Sectional Data- The Effect of Temporal Changes in Health Practices

    Jul 1, 2011, 00:00

  • Costos de la Esclerosis Múltiple en Colombia

    Jul 1, 2011, 00:00

  • Reviewer Acknowledgement

    Jul 1, 2011, 00:00

  • Factores Asociados al Incumplimiento de los Tratamientos con Antidepresivos en Santiago, Chile

    Jul 1, 2011, 00:00

  • Development and Validation of a Microsimulation Economic Model to Evaluate the Disease Burden Associated with Smoking and the Cost-Effectiveness of Tobacco Control Interventions in Latin America

    Jul 1, 2011, 00:00

  • Is Equity of Access to Health Care Achievable in Latin America?

    Jul 1, 2011, 00:00

  • Table of Contents

    Jul 1, 2011, 00:00

  • Evaluación Económica de un Programa de Inmunización Infantil en México Basado en la Vacuna Neumocócica Conjugada 13-Valente

    Jul 1, 2011, 00:00

  • Estimating the SF-6D Value Set for a Population-Based Sample of Brazilians

    Jul 1, 2011, 00:00

  • Development and Validation of the Influenza Intensity and Impact Questionnaire (FluiiQ™)

    Jul 1, 2011, 00:00

  • The Costs of Type 2 Diabetes Mellitus Outpatient Care in the Brazilian Public Health System

    Jul 1, 2011, 00:00

  • Ideal Vial Size for Bortezomib- Real-World Data on Waste and Cost Reduction in Treatment of Multiple Myeloma in Brazil

    Jul 1, 2011, 00:00

  • The Impact of Non-Severe Hypoglycemic Events on Work Productivity and Diabetes Management

    Jul 1, 2011, 00:00

  • Cost-Effectiveness of Supervised Exercise Therapy in Heart Failure Patients

    Jul 1, 2011, 00:00

  • Influence of Organic and Functional Dyspepsia on Work Productivity- The HEROES-DIP Study

    Jul 1, 2011, 00:00

  • Editorial Board

    Jul 1, 2011, 00:00

  • Survival Time Outcomes in Randomized, Controlled Trials and Meta-Analyses- The Parallel Universes of Efficacy and Cost-Effectiveness

    Jul 1, 2011, 00:00

  • Adjusting for Patient Crossover in Clinical Trials Using External Data- A Case Study of Lenalidomide for Advanced Multiple Myeloma

    Jul 1, 2011, 00:00

  • Costo Efectividad de Posaconazol versus Fluconazol/Itraconazol en el Tratamiento Profiláctico de las Infecciones Fúngicas Invasivas en México

    Jul 1, 2011, 00:00

  • Comparison of EQ-5D Scores among Anthracycline-Containing Regimens followed by Taxane and Taxane-Only Regimens for Node-Positive Breast Cancer Patients after Surgery- The N-SAS BC 02 Trial

    Jul 1, 2011, 00:00

  • Chronic Hepatitis B Treatment- The Cost-Effectiveness of Interferon Compared to Lamivudin e

    Jul 1, 2011, 00:00

  • Implementing Pharmacoeconomic Guidelines in Latin America- Lessons Learned

    Jul 1, 2011, 00:00

  • Cost Utility Analysis Based on a Head-to-Head Phase 3 Trial Comparing Ustekinumab and Etanercept in Patients with Moderate-to-Severe Plaque Psoriasis- A Canadian Perspective

    Jul 1, 2011, 00:00

  • Precios de Referencia Internacional y Análisis de Costo Minimización para la Regulación de Precios de Medicamentos en Colombia

    Jul 1, 2011, 00:00

  • Instructions for Authors

    Jul 1, 2011, 00:00

  • Insurance Status and Demographic and Clinical Factors Associated with Pharmacologic Treatment of Depression- Associations in a Cohort in Buenos Aires

    Jul 1, 2011, 00:00

  • Changes in Smokers' Attitudes Toward Intended Cessation Attempts in Japan

    Jul 1, 2011, 00:00

  • Costo-Efectividad del Cardiodesfibrilador Implantable en Pacientes con Factores de Riesgo de Muerte Súbita en Argentina

    Jul 1, 2011, 00:00

  • Análisis de la Satisfacción con los Cuidados en Salud a Través del Cuestionario EORTC IN-PATSAT32 en Pacientes con Cáncer de Mama, Linfoma no Hodgkin y Cáncer Colo-Rectal en Diferentes Etapas Clínicas. Relación con las Características Socio ...

    Jul 1, 2011, 00:00

  • Costo-Efectividad del Tratamiento de Salmeterol/Fluticasona en Comparación con Leucotrieno Montelukast para el Control del Asma Infantil

    Jul 1, 2011, 00:00

  • Instructions for Authors

    Jul 1, 2011, 00:00

  • The Use of a Decision Board to Elicit Brazilian Patients' and Physicians' Preferences for Treatment- The Case of Lupus Nephritis

    Jul 1, 2011, 00:00

  • Estimating Health State Utility Values for Comorbid Health Conditions Using SF-6D Data

    Jul 1, 2011, 00:00

  • Cost-Effectiveness Analysis of Linezolid, Daptomycin, and Vancomycin in Methicillin-Resistant Staphylococcus aureus- Complicated Skin and Skin Structure Infection Using Bayesian Methods for Evidence Synthesis

    Jul 1, 2011, 00:00

  • Development of a Transparent Interactive Decision Interrogator to Facilitate the Decision-Making Process in Health Care

    Jul 1, 2011, 00:00

  • Analysis of SF-6D Index Data- Is Beta Regression Appropriate?

    Jul 1, 2011, 00:00

  • Model-Based Economic Evaluation in Alzheimer's Disease- A Review of the Methods Available to Model Alzheimer's Disease Progression

    Jul 1, 2011, 00:00

  • Impact of Drug Treatment History on Comparative Effectiveness Research in Schizophrenia

    Jul 1, 2011, 00:00

  • Evaluación de la Calidad de Vida en Pacientes con Linfoma no Hodgkin y Cáncer Colo-Rectal en Diferentes Etapas Clínicas Atendidos en el Instituto Mexicano del Seguro Social

    Jul 1, 2011, 00:00

  • Análise de Custo-Efetividade da Sinvastatina versus Atorvastatina na Prevenção Secundária de Eventos Cardiovasculares no Sistema Único de Saúde Brasileiro

    Jul 1, 2011, 00:00

  • Patrones de Tratamiento y Costo de Atención del Cáncer de Mama Avanzado Con Falla a Antraciclinas y Taxanos en 3 Hospitales Públicos de México

    Jul 1, 2011, 00:00

  • Health Status and Health Behaviors in Venezuelan Pharmacy Students

    Jul 1, 2011, 00:00

  • Short-Term Therapy with Enoxaparin or Unfractionated Heparin for Venous Thromboembolism in Hospitalized Patients- Utilization Study and Cost-Minimization Analysis

    Jul 1, 2011, 00:00

  • Copyright/Subscription

    Jul 1, 2011, 00:00

  • Deriving a Preference-Based Measure for Cancer Using the EORTC QLQ-C30

    Jul 1, 2011, 00:00

  • Estimation and Comparison of EQ-5D Health States' Utility Weights for Pneumoccocal and Human Papillomavirus Diseases in Argentina, Chile, and the United Kingdom

    Jul 1, 2011, 00:00

  • Editorial Board

    Jul 1, 2011, 00:00

  • Incorporating Children's and Their Parents' Perspectives into Condition-Specific Quality-of-Life Instruments for Children with Cerebral Palsy- A Qualitative Study

    Jul 1, 2011, 00:00

  • Copyright/Subscription

    Jul 1, 2011, 00:00

  • Utility-Based Quality of Life of Overweight and Obese Adolescents

    Jul 1, 2011, 00:00

  • Costos de la Diabetes en Ameŕica Latina- Evidencias del Caso Mexicano

    Jul 1, 2011, 00:00

  • Pharmacoeconomics and Outcomes Research in Latin America- A Promising and Developing Field

    Jul 1, 2011, 00:00

  • 1st Special Issue- Pharmacoeconomics Outcomes Research in Latin America

    Jul 1, 2011, 00:00

  • Health-Related Quality of Life of Patients Recieving Hemodialysis and Peritoneal Dialysis in São Paulo, Brazil- A Longitudinal Study

    Jul 1, 2011, 00:00

  • Pharmacoeconomic Analysis of Capecitabine versus 5-Fluorouracil/Leucovorin as Adjuvant Therapy for Stage III Colon Cancer in Taiwan

    Jul 1, 2011, 00:00

  • Calidad de Vida en Mujeres Mexicanas con Cáncer de Mama en Diferentes Etapas Clínicas y su Asociación con Características Socio-Demográficas, Estados Co-Mórbidos y Características del Proceso de Atención en el Instituto Mexicano del Seguro ...

    Jul 1, 2011, 00:00

  • Cost-Effectiveness of Nucleoside Reverse Transcriptase Inhibitor Pairs in Efavirenz-Based Regimens for Treatment-Naïve Adults with HIV Infection in the United States

    Jul 1, 2011, 00:00

  • Evaluating Patient-Reported Outcome Measurement Comparability between Paper and Alternate Versions, Using the Lung Function Questionnaire as an Example

    Jul 1, 2011, 00:00

  • The Responsiveness of Quality of Life Utilities to Change in Depression- A Comparison of Instruments (SF-6D, EQ-5D, and DFD)

    Jul 1, 2011, 00:00

  • Health Care Resource Use and Costs in Opioid-Treated Patients with and without Constipation in Brazil

    Jul 1, 2011, 00:00

  • Gastos do Ministério da Saúde do Brasil com Medicamentos de Alto Custo- Uma Análise Centrada no Paciente

    Jul 1, 2011, 00:00

  • The Burden of Moderate/Severe Premenstrual Syndrome and Premenstrual Dysphoric Disorder in a Cohort of Latin American Women

    Jul 1, 2011, 00:00

  • The Long-Term Outcomes and Costs of Diabetes Mellitus among Renal Transplant Recipients- Tacrolimus versus Cyclosporine

    Jun 1, 2011, 00:00

  • Practical Implications of Differential Discounting in Cost-Effectiveness Analyses with Varying Numbers of Cohorts

    Jun 1, 2011, 00:00

  • Taking Conjoint Analysis to Task

    Jun 1, 2011, 00:00

  • Examining Web Equivalence and Risk Factor Sensitivity of the COPD Population Screener

    Jun 1, 2011, 00:00

  • Erratum

    Jun 1, 2011, 00:00

  • Impact of Depression on Work Productivity and Its Improvement after Outpatient Treatment with Antidepressants

    Jun 1, 2011, 00:00

  • Cost-Effectiveness of Granulocyte Colony–Stimulating Factor Prophylaxis for Febrile Neutropenia in Breast Cancer in the United Kingdom

    Jun 1, 2011, 00:00

  • Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies- Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices- Part 2

    Jun 1, 2011, 00:00

  • Economic Impact of Nonpersistence with Antidepressant Treatment in the Adult Population of Quebec- A Comparative Cost-Effectiveness Approach

    Jun 1, 2011, 00:00

  • Estimation of a Multiattribute Utility Function for the Spanish Version of the TooL Questionnaire

    Jun 1, 2011, 00:00

  • Early Dialogue Between the Developers of New Technologies and Pricing and Reimbursement Agencies- A Pilot Study

    Jun 1, 2011, 00:00

  • Ticagrelor versus Genotype-Driven Antiplatelet Therapy for Secondary Prevention after Acute Coronary Syndrome- A Cost-Effectiveness Analysis

    Jun 1, 2011, 00:00

  • Pharmaceutical Priority Setting and the Use of Health Economic Evaluations- A Systematic Literature Review

    Jun 1, 2011, 00:00

  • Editorial Board

    Jun 1, 2011, 00:00

  • Author Reply: Application of the Disease-Specific Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) Questionnaire in a General Population: Results from a French Panel Study

    Jun 1, 2011, 00:00

  • Using Health State Utility Values from the General Population to Approximate Baselines in Decision Analytic Models when Condition-Specific Data are Not Available

    Jun 1, 2011, 00:00

  • Perspectives on “Early Dialogue” between a Manufacturer and Health Technology Assessment Agencies

    Jun 1, 2011, 00:00

  • A Meta-Analysis of Osteoporotic Fracture Risk with Medication Nonadherence

    Jun 1, 2011, 00:00

  • Hospital Resource Utilization and Treatment Cost of Skeletal-Related Events in Patients with Metastatic Breast or Prostate Cancer- Estimation for the Portuguese National Health System

    Jun 1, 2011, 00:00

  • Instructions for Authors

    Jun 1, 2011, 00:00

  • Another Study Showing that Two Preference-Based Measures of Health-Related Quality of Life (EQ-5D and SF-6D) are Not Interchangeable. But Why Should We Expect Them to be?

    Jun 1, 2011, 00:00

  • The Use of Quality-Adjusted Life-Years in the Economic Evaluation of Health Technologies in Spain- A Review of the 1990–2009 Literature

    Jun 1, 2011, 00:00

  • Utility Scores and Treatment Preferences for Clinical Early-Stage Cervical Cancer

    Jun 1, 2011, 00:00

  • Patient-Reported Pediatric Quality of Life Inventory™ 4.0 Generic Core Scales in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder and Comorbid Psychiatric Disorders- Feasibility, Reliability, and Validity

    Jun 1, 2011, 00:00

  • Copyright/Subscription

    Jun 1, 2011, 00:00

  • Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making- Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices- Part 1

    Jun 1, 2011, 00:00

  • Economic Evaluation of Reamed versus Unreamed Intramedullary Nailing in Patients with Closed and Open Tibial Fractures- Results from the Study to Prospectively Evaluate Reamed Intramedullary Nails in Patients with Tibial Fractures (SPRINT)

    Jun 1, 2011, 00:00

  • Health Utilities Associated with Hemoglobin Levels and Blood Loss in Postmenopausal Women- The Women's Health Initiative

    Jun 1, 2011, 00:00

  • The Chimera of Population Norms

    Jun 1, 2011, 00:00

  • Table of Contents

    Jun 1, 2011, 00:00

  • ISPOR States Its Position on Network Meta-Analysis

    Jun 1, 2011, 00:00

  • Development of the EXACT-U- A Preference-Based Measure to Report COPD Exacerbation Utilities

    Jun 1, 2011, 00:00

  • The Association between Statin use and Outcomes Potentially Attributable to an Unhealthy Lifestyle in Older Adults

    Jun 1, 2011, 00:00

  • Conjoint Analysis Applications in Health—a Checklist- A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force

    Jun 1, 2011, 00:00

  • Trends in Health Care Utilization in British Columbia Following Public Coverage for Tiotropium

    Jun 1, 2011, 00:00

  • PMH77 UTILIZATION PATTERN OF PSYCHOTHERAPY AS AN ADJUNCT TO PHARMACOTHERAPY AMONG AMBULATORY BIPOLAR DISORDER PATIENTS

    May 1, 2011, 00:00

  • PIH45 MULTILEVEL ANALYSIS TO MEASURE HOSPITAL VARIATION- THE CASE OF CESAREAN DELIVERY

    May 1, 2011, 00:00

  • PMS7 THE IMPACT OF RHEUMATOID ARTHRITIS ON CARDIOVASCULAR MORBIDITY IN A HIGH RISK MEDICAID POPULATION

    May 1, 2011, 00:00

  • PHP54 THE IMPACT OF PHARMACIST-CONDUCTED MEDICATION RECONCILIATION WITH PATIENT COUNSELING AT HOSPITAL ADMISSION

    May 1, 2011, 00:00

  • PCV13 BURDEN OF COMORBIDITIES AMONG PATIENTS WITH ATRIAL FIBRILLATION

    May 1, 2011, 00:00

  • PND50 UNDERSTANDING HEALTH RELATED QUALITY OF LIFE CHANGES AND ISSUES RELATED TO DISEASE MODIFYING DRUGS AMONG MULTIPLE SCLEROSIS PATIENTS- A QUALITATIVE STUDY

    May 1, 2011, 00:00

  • PDB18 FACTORS ASSOCIATED WITH ROUTINE PROPER MONITORING OF DIABETES CARE AMONG THE NON-INSTITUTIONALIZED POPULATION IN THE UNITED STATES- A RETROSPECTIVE ANALYSIS OF THE 2007 MEDICAL EXPENDITURE PANEL SURVEY (MEPS)

    May 1, 2011, 00:00

  • QA3 DOES COST-EFFECTIVENESS ANALYSIS DISCRIMINATE AGAINST PATIENTS WITH SHORTER LIFE EXPECTANCY?

    May 1, 2011, 00:00

  • PGI25 STRUCTURED MANAGEMENT STRATEGY VERSUS USUAL PRIMARY CARE FOR GASTROESOPHAGEAL REFLUX DISEASE- META-ANALYSIS OF FIVE EUROPEAN CLUSTER RANDOMIZED TRIALS ASSESSING HEALTH CARE UTILIZATION COSTS

    May 1, 2011, 00:00

  • PCV76 PATIENT SYMPTOM EXPERIENCES FOLLOWING A MYOCARDIAL INFARCTION

    May 1, 2011, 00:00

  • PCV99 MEDICAL RESOURCE UTILIZATION AND COSTS FOLLOWING HOSPITALIZATION OF PATIENTS WITH CHRONIC HEART FAILURE IN THE UNITED STATES

    May 1, 2011, 00:00

  • PCV101 EXPLORING GENDER DISPARITIES IN PREVENTIVE CARE UTILIZATION AMONGST THE UNITED STATES POPULATION

    May 1, 2011, 00:00

  • PCV32 BUDGET IMPACT ANALYSIS OF INCREASING LMWH/FXI UTILIZATION

    May 1, 2011, 00:00

  • PMD20 COST-EFFECTIVENESS ANALYSIS OF A NEW INDEX FOR PROSTATE CANCER DETECTION

    May 1, 2011, 00:00

  • PIH13 THE COST-EFFECTIVENESS OF THE LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM (LNG-IUS, MIRENA®) FOR THE TREATMENT OF HEAVY MENSTRUAL BLEEDING IN THE UNITED STATES

    May 1, 2011, 00:00

  • PMD14 COMPARISON OF PER DISCHARGE COSTS OF THE REPAIR OF INCISIONAL/VENTRAL HERNIAS PERFORMED WITH PERMACOL™ AND STRATTICE™ IN THE UNITED STATES

    May 1, 2011, 00:00

  • PHP106 DISPARITY IN ACCESS TO NOVEL DIABETIC AGENTS FOR MEDICARE PART D ELDERLY COMPARED TO COMMERCIAL INSURED PATIENTS- INSIGHT INTO DOWNSTREAM EFFECTS OF CMS FORMULARY COVERAGE GUIDELINES FOR PDP'S

    May 1, 2011, 00:00

  • CO2 REAL-WORLD COST-EFFECTIVENESS ANALYSIS OF CANCER DRUGS- COMPARATIVE EFFECTIVENESS RESEARCH USING RETROSPECTIVE CANADIAN REGISTRY DATA BEFORE AND AFTER DRUG APPROVAL

    May 1, 2011, 00:00

  • PHP83 HTA DECISION DRIVERS FOR ACCEPTANCE OF HIGH ICER SUBMISSIONS AND REJECTION OF LOW ICER SUBMISSIONS

    May 1, 2011, 00:00

  • PIN12 ECONOMIC ANALYSIS OF CEFTIOFUR HYDROCHLORIDE FOR TREATMENT OF BOVINE CLINICAL MASTITIS CAUSED BY GRAM-NEGATIVE PATHOGENS IN DAIRY COWS IN THE UNITED STATES

    May 1, 2011, 00:00

  • PMH70 WHAT DROVE THE DRAMATIC SLOWDOWN IN PSYCHIATRIC DRUG SPENDING GROWTH IN THE UNITED STATES

    May 1, 2011, 00:00

  • PCN59 COST EFFECTIVENESS ANALYSIS OF LAPATINIB/CAPECITABINE (LC) VERSUS TRASTUZUMAB/CAPECITABINE (TC) IN PATIENTS WITH METASTATIC BREAST CANCER ERBB2+ AFTER PROGRESSION TO THE FIRST SCHEME OF TRASTUZUMAB

    May 1, 2011, 00:00

  • PGI26 PATIENT CHARACTERISTICS ASSOCIATED WITH USE OF ENTERAL VERSUS PARENTERAL ACID SUPPRESSIVE AGENTS IN INTENSIVE CARE UNIT PATIENTS

    May 1, 2011, 00:00

  • PRS38 EFFECT OF HAVING A PRESCRIPTION DRUG PLAN ON ASTHMA PATIENTS' USE OF CONTROLLER MEDICATIONS

    May 1, 2011, 00:00

  • PCV55 COST-MINIMIZATION ANALYSIS OF THROMBOPROPHYLAXIS FOLLOWING ELECTIVE TOTAL HIP ARTHROPLASTY

    May 1, 2011, 00:00

  • PDB41 TREATMENT GAPS AMONG GROWTH HORMONE USERS IN A NATIONAL MANAGED CARE POPULATION IN THE UNITED STATES

    May 1, 2011, 00:00

  • PIH21 COST-UTILITY ANALYSIS OF DIENOGEST VERSUS GNRH ANALOGUE IN THE TREATMENT OF ENDOMETRIOSIS-ASSOCIATED PELVIC PAIN IN SLOVAKIA

    May 1, 2011, 00:00
  • «
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130 (current)
  • »